发明名称 |
Method and compounds for generation of iPSCs |
摘要 |
The present invention is based on the seminal concept of combining genomics and chemical biology to identify new agents useful for induced pluripotent stem cell (iPSC) generation. The invention provides a method of generating an iPSC utilizing agents that antagonize a cell specific gene or upregulate expression or activity of a nuclear reprogramming gene, as well as a method of screening for such agents. |
申请公布号 |
US9410128(B2) |
申请公布日期 |
2016.08.09 |
申请号 |
US201213402664 |
申请日期 |
2012.02.22 |
申请人 |
Sanford-Burnham Medical Research Institute |
发明人 |
Rana Tariq M. |
分类号 |
C12N5/00;C12N5/06;C12N5/08;C07H21/04;C12N5/074;G01N33/50;C07H21/02 |
主分类号 |
C12N5/00 |
代理机构 |
DLA Piper LLP (US) |
代理人 |
DLA Piper LLP (US) |
主权项 |
1. An in vitro method of generating an induced pluripotent stem cell (iPSC) comprising:
a) contacting a human or mouse fibroblast cell with nuclear reprogramming factors, the nuclear reprogramming factors being OCT4, SOX2, KLF4 and C-MYC, wherein the nuclear reprogramming factors are encoded by one or more polynucleotides; and b) contacting the cell of (a) with an agent that inhibits COX-2 expression or activity, wherein the agent is a polynucleotide, and wherein reprogramming efficiency is increased as compared to generation of an iPSC without contacting the cell with the agent, thereby generating an iPS cell. |
地址 |
La Jolla CA US |